Risk-adapted use of intravesical chemotherapy.
Lerner
Seth P
SP
Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA. slerner@bcm.tmc.edu
Au
Jessie L-S
JL
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D012307:Risk Factors; D016879:Salvage Therapy / Q000379:methods*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine